RHJA
Rice Hall James & Associates Portfolio holdings
AUM
$1.86B
This Quarter Return
+15.94%
1 Year Return
+33.9%
3 Year Return
+119.1%
5 Year Return
+206.57%
10 Year Return
+613.71%
AUM
$1.73B
AUM Growth
+$1.73B
(+9.7%)
Cap. Flow
-$46.6M
Cap. Flow
% of AUM
-2.7%
Top 10 Holdings %
Top 10 Hldgs %
25.39%
Holding
270
New
10
Increased
28
Reduced
188
Closed
10
Top Buys
| 1 |
Establishment Labs
ESTA
|
$9.9M |
| 2 |
VRNA
Verona Pharma
VRNA
|
$8.81M |
| 3 |
Prestige Consumer Healthcare
PBH
|
$6.88M |
| 4 |
Addus HomeCare
ADUS
|
$3.75M |
| 5 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$3.42M |
Top Sells
| 1 |
BBBY
Bed Bath & Beyond, Inc.
BBBY
|
$16.4M |
| 2 |
Stride
LRN
|
$10.7M |
| 3 |
NXGN
NextGen Healthcare, Inc. Common Stock
NXGN
|
$9.14M |
| 4 |
Axos Financial
AX
|
$7.76M |
| 5 |
Cambium Networks
CMBM
|
$3.8M |
Sector Composition
| 1 | Healthcare | 30.1% |
| 2 | Technology | 23.66% |
| 3 | Industrials | 19.76% |
| 4 | Consumer Discretionary | 6.36% |
| 5 | Communication Services | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Puma Biotechnology
PBYI
$258M
| $1.43M | 0.08% |
329,870
-33,796
| -9% | -$146K |
|
202
Johnson & Johnson
JNJ
$429B
| $1.43M | 0.08% |
9,111
| – | – |
|
203
Coda Octopus Group
CODA
$91.1M
| $1.42M | 0.08% |
235,225
-15,803
| -6% | -$95.1K |
|
204
Zynex
ZYXI
$45.1M
| $1.31M | 0.08% |
120,429
+91,822
| +321% | +$1,000K |
|
|
OPTN
205
DELISTED
OptiNose
OPTN
| $1.3M | 0.08% |
66,992
-3,013
| -4% | -$58.3K |
|
206
Bruker
BRKR
$4.45B
| $1.29M | 0.07% |
17,524
| – | – |
|
207
Mirum Pharmaceuticals
MIRM
$3.75B
| $1.26M | 0.07% |
42,840
-10,539
| -20% | -$311K |
|
208
Exxon Mobil
XOM
$477B
| $1.21M | 0.07% |
12,057
+8,407
| +230% | +$841K |
|
209
Crane Co
CR
$10.5B
| $1.15M | 0.07% |
9,713
| – | – |
|
210
Zimmer Biomet
ZBH
$20.8B
| $1.11M | 0.06% |
9,159
| – | – |
|
211
Bio-Techne
TECH
$8.3B
| $1.11M | 0.06% |
14,432
| – | – |
|
|
212
Cambium Networks
CMBM
$18.9M
| $1.11M | 0.06% |
184,214
-632,577
| -77% | -$3.8M |
|
213
Eli Lilly
LLY
$661B
| $1.1M | 0.06% |
1,890
| – | – |
|
214
UroGen Pharma
URGN
$896M
| $1.05M | 0.06% |
69,892
-5,288
| -7% | -$79.3K |
|
215
Knight Transportation
KNX
$7.07B
| $1.03M | 0.06% |
17,877
| – | – |
|
216
Entravision Communication
EVC
$225M
| $1.01M | 0.06% |
243,230
-11,003
| -4% | -$45.9K |
|
217
Berkshire Hathaway Class B
BRK.B
$1.08T
| $999K | 0.06% |
2,800
| – | – |
|
218
Dover
DOV
$24B
| $955K | 0.06% |
6,210
-10
| -0.2% | -$1.54K |
|
219
Treehouse Foods
THS
$917M
| $905K | 0.05% |
21,830
-33
| -0.2% | -$1.37K |
|
220
Exelixis
EXEL
$9.95B
| $903K | 0.05% |
37,645
-74
| -0.2% | -$1.78K |
|
221
Edwards Lifesciences
EW
$47.7B
| $888K | 0.05% |
11,649
| – | – |
|
222
TruBridge
TBRG
$299M
| $849K | 0.05% |
75,829
-122,050
| -62% | -$1.37M |
|
223
Scholar Rock
SRRK
$3.3B
| $829K | 0.05% |
44,080
-3,293
| -7% | -$61.9K |
|
224
Kirby Corp
KEX
$4.95B
| $806K | 0.05% |
10,268
| – | – |
|
225
Denny's
DENN
$230M
| $796K | 0.05% |
73,137
-4,868
| -6% | -$53K |
|